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Hydrolase Activities in the Rat Aorta
II. Effects of Hypertension Alone and in Combination with Diabetes Mellitus
HARVEY WOLINSKY, LOIC CAPRON, SIDNEY GOLDFISCHER, FREDERIQUE CAPRON, BERNICE COLTOFF-SCHILLER, AND LISA E. KASAK SUMMARY Hypertension is an important risk factor for atherosclerosis and often occurs in association with diabetes mellitus. Specific activities of hydrolases in homogenates of aortas from rats with renal-clip hypertension, normotension following a period of hypertension, and hypertension combined with streptozotocin-induced diabetes mellitus were measured. Enzymes included: neutral a-glucosidase, and lysosomal JV-acetyl-0-gIucosaminidase, figalactosidase, cathepsin C, acid a-glucosidase, and acid cholesteryl esterase. After 6 or 12 weeks of hypertension, specific activities of all enzymes measured were significantly increased, levels ranging from 24% above normal for cathepsin C to 351% above normal forA r -acetyl-/3-glucosaminidase. Six weeks of normotension following 6 weeks of hypertension resulted in restoration to normal of four of the six enzyme activities; the remaining two enzymes were significantly below normal levels. Combined hypertension and diabetes mellitus showed smooth muscle cell levels of four of the five hydrolases measured to be significantly lower than those present with hypertension alone. In every instance, histochemical studies of aortas showed acid phosphatase and N-acetyU/J-glucosaminidase activities which corresponded to the biochemical findings. These findings indicate profound and discrete effects of two clinical risk factors on vascular smooth muscle cell lysosomes.
HYPERTENSION is a major risk factor for the development of atherosclerosis and its sequelae in man. 1 Increased vascular permeability has been invoked as a mechanism for this effect of hypertension, since experimental hypertension results in increased permeability of the vessel wall to many circulating proteins and cholesterol. 2 -3 Presumably, this is reflected in enhanced cellular uptake of circulating materials and stimulation of lysosomes in vas-cular smooth muscle cells which occurs under these conditions. 4 ' 5 Diabetes mellitus is another risk factor for atherosclerosis in man 6 which often occurs in association with hypertension. 6 " 8 Permeability of the diabetic vessel wall is reported to be normal 9 or increased. 10 Yet, in experimental diabetes mellitus, levels of hydrolases, including those in lysosomes, are decreased in vascular smooth muscle cells as shown in the accompanying paper."
When more than one risk factor is present, each makes an independent contribution to the clinical risk of disease. 1 The difference we have observed between the lysosomal responses to two common risk factors, diabetes mellitus and hypertension, therefore was intriguing and stimulated the present studies. Two objectives were sought. First, we wished to extend our previous observations on lysosomal enzymes in hypertension to other hydrolases, including acid cholesteryl esterase, which is involved in lipoprotein metabolism. We also determined whether removal of hypertension lowered lysosomal levels. Second, it was of interest to study the effects, at the cellular level, of combining experimental hypertension and diabetes mellitus in the same animal model to determine whether the resulting hydrolase activities reflected the contribution of each.
Methods
Male Sprague-Dawley rats (Marland Farms), age 6 weeks and weighing 175-200 g at the outset of the experiment, were made hypertensive by placing a silver clip, internal diameter 0.25 mm, on the left renal artery. In the Sprague-Dawley rat, hypertension, defined as a systolic blood pressure greater than 150 mm Hg, generally ensued 2 weeks after surgery. Blood pressures were taken every week for the first 4 weeks and every 2 weeks thereafter. The method of taking blood pressures by tail cuff is described elsewhere. 12 To restore elevated blood pressure to normal, the previously placed renal artery clip was opened fully with clamps, and restoration of bounding pulsations in the renal artery could be palpated immediately. In most rats, a sharp fall in systolic blood pressure to near normal occurred within 1 week; in some, a moderate drop in the first week was followed by a further slight decline to near normal in the second. No further change was seen after this. These rats will be called the hypertensive-normotensive group. All surgical procedures involving the clips were matched in time by sham operations in all other rats.
Rats were made diabetic by injection with a single dose of 10 mg of streptozotocin (Upjohn) (approximately 55 mg/kg body weight) dissolved in 0.5 ml of 0.9% saline with 0.02 M sodium citrate, pH 4.5. Injections were made into the jugular veins of nonfasted animals. Details of criteria used for diabetes mellitus, bleeding schedules, and methods of blood glucose measurement are given in the preceding paper." All rats were killed by exsanguination via the abdominal aorta while under ether anesthesia.
Experimental Designs

Hypertension and Hypertension followed by Normotension
The experimental design consisted of two 6-week periods. After documentation of hypertension for 6 weeks in the clipped group, two subgroups, controls (C) and hypertensives (H), were killed. The remaining hypertensive rats were further divided into sustained hypertensive (HH) and hypertensive-normotensive (HC) groups. After a documented 6-week period of stable reduced blood pressure in the latter group, three groups, HH, HC. and an agematched control group (CC). were killed. The H group sustained the same duration of hypertension as the HC group (6 weeks).
Combined Diabetes Mellitus and Hypertension
Four groups were studied: controls (C) . diabetic (D). hypertensive-diabetic (HD), and hypertensive (H). Rats in groups HD and H had a renal artery clip placed at age 6 weeks. One week later (before an increase in systolic blood pressure could be detected in those clipped), rats in groups HD and D were injected with streptozotocin; overt diabetes ensued in 3 days. The experimental period was 8 weeks of documented hypertension and/or diabetes mellitus, after which all rats were killed. Studies on vessels of all groups in this experiment were done simultaneously.
Morphological and Cytochemical Studies
Light and electron microscopic studies were done exactly as described elsewhere."
Biochemical Studies
These were carried out on intima-media fragments of thoracic aortic segments as described elsewhere" with the exception that, in the hypertension and hypertensionnormotension experiments only, three aortas, pooled and homogenized in 4.5 ml of sucrose-EDTA solution, represent each experimental sample.
Enzyme Assays*
Glycosidases and cathepsin C were assayed fluorometrically in the same manner as previously discussed." 114 Optimal incubation conditions for neutral a-glucosidase, /3-galactosidase, cathepsin C, jV-acetyl-/3-glucosaminidase, and acid a-glucosidase in vessels from H and HD groups were identical to those given elsewhere for C and D groups." Incubation periods ranged from 15 to 150 minutes at 37°C depending on the enzyme studied. The activity of a-mannosidase, measured previously in C and D aortas at pH 5.9 and thought to be a Golgi enzyme,"-l5 was not assayed here because pH optimum curves obtained on H and HD aortas showed an additional prominent peak of activity at pH 4.5, probably due to the lysosomal a-mannosidase.' 5 The presence of two enzymes with overlapping pH optima prevented unambiguous determinations of the activity of each. Acid cholesteryl esterase in H aortas showed linear activity and the same optimum conditions as were shown to be necessary for this enzyme in aortas from C and D groups." The incubation period used was 2 hours. In HD vessels, however, kinetics for this enzyme were not linear under these conditions. Therefore, this enzyme was not measured in the hypertensive-diabetic experiment.
Under the conditions described, all enzyme activities were linear with time and protein concentration. (See accompanying paper" for details of criteria, units of activity, DNA, and protein determinations.)
Results
Characteristics of Animal Groups
For rats in the hypertension and hypertension-normotension experiments, final body weights, blood pressures, and DNA contents per pooled sample of three aortas are shown in Table 1 . After both the 6-and 12-week experimental periods, body weights of hypertensive rats were * Trivial names for enzymes are used throughout. Formal nomenclature recommended by the International Union of Biochemistry may be found elsewhere. 13 less than those of controls (P < 0.001), blood pressures and heart-body weight ratios were greater (P < 0.001), and aortic DNA contents were larger (P < 0.01). Hypertensive-normotensive rats achieved final body weights greater than sustained hypertensive rats (P < 0.01) but still less than controls (P < 0.02). Mean systolic blood pressure of hypertensive-normotensive rats did not differ from controls during the normotensive period (0.1 > P > 0.05). Heart weight-to-body weight ratios reflected these pressure changes (Table 1) . Interestingly, despite the normotensive period in reversed rats, aortic DNA contents remained high and did not return toward normal. For the hypertension-diabetes experiment, all the above measurements as well as blood glucose values of the four groups are shown in Table 2 . The mean body weight differed significantly in each group (P < 0.001). Blood glucose tended to be higher in hypertensive groups than in corresponding normotensive groups, but not significantly so (P> 0.05).
Blood pressures of hypertensive and hypertensive-diabetic groups were similar (P > 0.2), as were those of control and diabetic groups (P > 0.05). Heart weightbody weight ratios reflected these pressures. That this ratio was greater in diabetic groups than in nondiabetic groups (P < 0.001 for C vs. D and P < 0.05 for H vs. HD) may reflect loss of body fat in diabetics. DNA contents of aortic pools from hypertensive rats, but not from hypertensive-diabetic rats, were greater than normal (P <0.02).
Biochemical Findings
The kinetic behavior of all aortic enzymes studied from both hypertensive and hypertensive-diabetic groups is summarized in Figure 1 (refer to Figure 1 of the accompanying paper" for similar data on control and diabetic animals). A linear relationship was found between substrate hydrolyzed and protein-time product"" for each enzyme studied. Differences between activities of aortas from H and HD groups for most enzymes were noted during kinetic studies. Figure 2A shows the biochemical findings in pooled aortas of control and hypertensive groups at the 6-week point. Specific activity (calculated on DNA basis) of each hydrolytic enzyme studied was greater in hypertensive vessels than in controls, with the percent increase above controls ranging from 24% for cathepsin C to 351% for yV-acetyI-/3-glucosaminidase. Figure 2B summarizes the second 6-week period of the experiment. Control and hypertensive aortas again showed differences for each enzyme studied with the percent increase above control ranging from 41% for cathepsin C to 231% for /V-acetyl-/3-glucosaminidase. Following return of blood pressure to normal levels, the specific activity of each enzyme fell significantly below hypertensive levels measured after 6 or 12 weeks. Al- though four or six enzymes measured returned to levels no different from controls, interestingly, specific activities of cathepsin C and /V-acetyl-/3-glucosaminidase fell to levels significantly below controls (79% of controls for both). The reasons for this remain unknown.
Hypertension and Hypertension-Normotension Experiments
Mixing experiments were carried out to test the possibility that the increased enzyme activities in homogenates of hypertensive aortas were due to an activator. Table 3 shows specific activities of A'-acetyl-/3-glucosaminidase after mixing different proportions of homogenates from control and hypertensive rats. Activities observed fell close to those calculated from the original homogenates.
Hypertension-Diabetes Experiment
After 8 weeks of hypertension alone or diabetes alone ( Fig. 3 ) increases or decreases, respectively, in all enzymes were seen, which corresponded to our observations in the previous experiment (Fig. 2, A and B ) and in the accompanying paper" (P < 0.001 for every comparison of control vs. hypertensive or control vs. diabetic, except cathepsin C in the latter, where P < 0.05). In diabetics, levels of aortic enzymes compared to normals ranged from 55% for yV-acetyl-/3-glucosaminidase to 80% for acid aglucosidase. In hypertensives, increases in all aortic enzymes above control values ranged from 70% for cathepsin C to 293% for yV-acetyl-/3-glucosaminidase.
The coexistence of hypertension and diabetes (HD, Fig.  3 ) resulted in significant depressions of four of the five enzymes measured, compared to levels with hypertension alone. In most cases, HD aortas had enzyme levels intermediate between controls and hypertensives and significantly different from both (all P < 0.001 except neutral a-glucosidase in HD vs. C, P < 0.05). However, in the case of cathepsin C, the ombination of hypertension and diabetes resulted in levels no different from those of controls (0.4 > P > 0.3). Only acid a-glucosidase levels in HD vessels were not significantly different from those of H vessels (0.4 > P > 0.3), perhaps due to the large scatter of these values.
Morphological Findings
Grossly, the aortic wall from hypertensive rats was thicker than that of normotensive animals, but aortas from normotensive rats with preceding hypertension were more similar to controls. Cytochemical results of incubation of aortic slices for acid phosphatase or N-acetyl-/3-glucosaminidase showed the marked clustering of increased numbers of lysosomes previous described in the hypertrophic smooth muscle cells of hypertensive vessels (Figs. 4, A  and B , compared to Fig. 1 in ref. 4) . Lysosomes were clearly less numerous in aortas from hypertensive-normotensive rats (Fig. 4C) and were similar to control aortas. Incubation of vessels from the four groups of rats of the hypertension-diabetes experiment showed a hierarchy of cytochemical activities which corresponded to the biochemical results (Fig. 5 ). Compared to controls (Fig. 5A) , aortic lysosomal activities were depressed in the diabetic rats ( Fig. 5B ) and stimulated in hypertensive rats (Fig.  5D ). Aortas from rats with the combination of hypertension and diabetes (Fig. 5C ) had activities similar to those of the controls.
Electron microscopic examination of tissues incubated for acid phosphatase activity confirmed the localization of enzyme reaction product in lysosomes and supported light microscopic findings with respect to the numbers of reactive lysosomes. Other aspects of aortic morphology assessed ultrastructurally were consistent with previous observations. 411 In diabetic aortas, no necrosis or other cellular abnormalities were seen. Muscle cells in hypertensive aortas were enriched in rough endoplasmic reticulum and Golgi structures, as well as lysosomes. Aortic cells of hypertensive-normotensive rats were smaller than cells of hypertensives and had many fewer of these organelles. Extracellular connective tissue matrix was very prominent in hypertensive, hypertensive-normotensive, and hypertensive-diabetic vessels. However, the latter two groups had fewer lysosomes than were seen with hypertension alone. The most common lysosome was the dense body, often containing a clear droplet of lipid-like material.
Discussion
Hypertension results in marked stimulation of smooth muscle cell metabolism, including the lysosomal system. 4 ' 5 ' 1 7 The increased vascular permeability which occurs in hypertension is thought to be a stimulus to the lysosomes, since it has been shown that intravenously injected tracers can be followed into the lysosomes of vascular smooth muscle cells. 18 The present study shows that a broad array of hydrolases located in several differ- (C) has reaction product comparable to the control (A). 800 x. VOL. 42, No. 6, JUNE 1978 ent subcellular structures are markedly increased. Among the several lysosomal enzymes studied here, the increase in acid cholesteryl esterase is perhaps most interesting in view of its important role in lipoprotein catabolism.' 9 ' 20 Specific activity of this enzyme in hypertensive aortas was increased approximately 65% above control values after both 6 and 12 weeks of hypertension (Fig. 2) . Increased hydrolase activities presumably reflect a cellular response to increased influx of materials. In this heightened metabolic state, the hypertensive cell may be unusually vulnerable to the introduction of other conditions which tend to increase the net influx of a specific circulating material or reduce the net hydrolytic capacity of the cell (see below).
The changes in hydrolase levels seen here after blood pressure was reduced to normal correspond well to previous physiological, 21 morphological, and biochemical 12 findings which showed marked regression of the smooth muscle mass to near normal levels. The quick and dramatic responses of vascular cell metabolism to intravascular pressure changes thus extends to subcellular levels of hydrolytic enzymes. Indeed, it appears that several aspects of metabolic activity or aortic cells, including their connective tissue synthesizing machinery, 12 ' 22 are quickly influenced by changes in blood pressure acting on the vessel wall. Despite the return of cellular hydrolases to normal levels per cell after a period of normotension, the number of cells present remains at the increased level seen with hypertension.
Most intriguing, perhaps, is our observation that the coexistence of hypertension and diabetes mellitus results in significantly lower levels of most hydrolases in the vascular smooth muscle cell than are found with similar degrees of hypertension alone. Thus, the depressing effects of diabetes mellitus on hydrolase activities seen under normotensive conditions 11 persist when another stimulus, hypertension, simultaneously is influencing cellular metabolism. These observations suggest that levels of hydrolase activities measured in this cell reflect a complex interplay of hormonal, mechanical, and perhaps many other influences present in the animal at that time. Thus, the functional significance that can be attached to the isolated finding of a "normal" level of a given hydrolytic enzyme remains unclear. This is evident in the hypertensive-diabetic rats in which the level of cathepsin C is "normal" (at the control level) despite the existence of marked changes in two major determinants of that level. Clearly, the situation here is hardly equivalent to being nonhypertensive and nondiabetic. The implication of this conclusion is that adequacy of a given hydrolytic enzyme level for total clearance of incoming substrate cannot be directly linked to the absolute cellular level of that enzyme, be it "normal" or "abnormal." It is plausible, therefore, that accumulation of a substrate could occur even if the measured level of the relevant hydrolytic enzyme were increased above control levels.
Appreciation of this point is critical to proper testing of an hypothesis advanced by deDuve 23 and Peters et al. 24 They proposed that atherosclerosis might reflect a relative deficiency of acid cholesteryl esterase in vascular tissue. Cholesterol ester accumulations, first within the lysosome, then spilling out into the extracellular matrix, would reflect a subtle but persistent inability by the vascular cell to hydrolyze completely all the poorly permeant esters. This hypothesis does not require the demonstration of absolute decreases in levels of this enzyme, but a deficiency relative to amounts of incoming substrate. Therefore, the report of an increased level of this enzyme in experimental atherosclerosis 25 does not rule out the possibility that it still is inadequate. Accumulation of increased lipid, particularly cholesteryl ester, within the lysosome may be more revealing about adequacy of the hydrolytic enzyme than is the measured level of the enzyme alone.
The most reasonable conclusion from the studies described here is that two important clinical risk factors have clear-cut effects on vascular smooth muscle cell metabolism, specifically on cellular hydrolases. Among the features of these risk factors which seem to be important are: the rates of influx of circulating materials into the wall, the concentrations of circulating lipoproteins (or other components) in the serum, and the levels of hydrolytic enzymes within the cell itself. Interactions of these determinants could result in impaired clearance of incoming or locally synthesized materials by the cell and combinations of deleterious effects could exacerbate the process. Careful dissection of each of these events and the mechanisms involved is needed to ascertain the validity of these formulations in the pathogenesis of atherosclerosis and other vascular diseases.
